Hologic Analyst Ratings
Evercore ISI Adjusts Price Target on Hologic to $76 From $78, Maintains In-line Rating
Hologic Analyst Ratings
Hologic Analyst Ratings
Argus Adjusts Price Target on Hologic to $95 From $89
Analysts Have Conflicting Sentiments on These Healthcare Companies: Ultragenyx Pharmaceutical (RARE), Hologic (HOLX) and Arbutus Biopharma (ABUS)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Community Health (CYH) and Hologic (HOLX)
Hologic Analyst Ratings
JPMorgan Adjusts Price Target on Hologic to $91 From $85
Hologic Analyst Ratings
Hologic's Strong Performance and Positive Outlook Reinforce Buy Rating
Hologic's Strategic Growth and Expansion: A 'Buy' Rating Analysis
Hologic (HOLX) Receives a Hold From RBC Capital
Analysts Conflicted on These Healthcare Names: Tilray (TLRY), Hologic (HOLX) and Bicycle Therapeutics (BCYC)
Hologic Analyst Ratings
RBC Capital Sticks to Its Hold Rating for Hologic (HOLX)
RBC Raises Price Target on Hologic to $81 From $76, Keeps Sector Perform Rating
Hologic Analyst Ratings
Hologic Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Elanco Animal Health (ELAN), Hologic (HOLX) and Centene (CNC)